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We present here the initial characterization of the mechanism of reversal of cellular resistance to Vinca alkaloids by phenoxazine (PZ). Changes 
in fluorescence upon cellular accumulation of PZ allowed measurement of the membrane transport kinetics in a sensitive KB-3-1 cell line and two 
multi-drug resistant (MDR) counterparts. The accumulation of PZ is characterized by two uptake routes, with pseudo-first order rate constants 
of 0.3 s-’ and 0.07 s-‘, while eftlux of PZ from cells revealed rate constants of 0.2 s-‘. PZ rapidly reaches teady-state concentrations within cells, 
which may make it more clinically useful than modulators that accumulate more slowly (e.g. verapamil). 
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1. INTRODUCTION 
Cell lines expressing resistance to treatment via one 
agent often develop a resistance to many unrelated 
drugs [l]. This multi-drug resistance (MDR), has been 
connected to the over-expression of a 170kDa glycopro- 
tein (pgp) typically located on the plasma membrane of 
the resistant cells. Although the function of this protein 
is not fully understood, it is associated with decreased 
accumulation of cytotoxic drugs within the cell, and has 
been postulated to act as an energy dependent multi- 
drug transporter [2]. 
Reversal of MDR has become a primary goal in the 
treatment of cancer. The most promising path toward 
this reversal seems to be co-treatment of cells with addi- 
tional agents that prevent efflux of drugs from resistant 
cells. These agents, referred to as modulators, range 
from calcium channel antagonists to drug analogs [3,4]. 
PZ exhibits effective modulation (9- to 12-fold) of vin- 
cristine accumulation of KHChR-8-5 (KB85) and GC3/ 
Cl (GC3) cell lines, while phenothiazine is almost com- 
pletely ineffective [5]. 
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Abbreviutionsr PZ, phenoxazine; MDR, multi-drug resistance; 2.1. Cell lines, cell culture and general chemicals 
DMEM, Dulbecco’s modified Eagle medium; PBS, phosphate-buff- Human epidermoid carcinoma KB-3-1 cells, a colchicine selected 
ered saline (150 mM NaCI, 20 mM sodium phosphate, pH 7.4). MDR variant KB-ChR-8-5, and a vinblastine selected MDR variant 
X = 0 Phenoxazine 
X = S Phenothiazine 
In this report, we have begun a series of experiments 
designed to probe the mechanism of modulation of 
MDR by PZ and related derivatives. The fluorescence 
of PZ is environmentally sensitive, providing a wealth 
of information about the physical status and location of 
the drug. Accumulation of PZ into KB cells is accompa- 
nied by a significant fluorescence increase due to entry 
of the drug into hydrophobic regions in the cells (see 
below), making measurement of transport processes 
straightforward. 
We have determined rate constants for the membrane 
flux of PZ in sensitive and MDR cells. The results of 
these experiments have provided key information in the 
elucidation of the mechanism of MDR reversal by PZ 
and the role of p-glycoprotein and cell morphology in 
this process. 
2. MATERIALS AND METHODS 
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KB-V-l (denoted KB3 1, KB85 and KBVl, respectively) were obtained 
from Dr. M. Gottesman [9] and maintained. as previously described 
[5,9]. PZ was purchased from Aldrich Chemical Co. (Milwaukee, WI). 
Phenothiazine and non-enzymatic ell dissociation solution were pur- 
chased from Sigma. 
2.2. Drug uptake and efflux studies 
For uptake studies, cells were grown from 48 to 72 h and harvested 
by washing with PBS for 30 s, followed by a 4 min incubation with 
non-enzymatic ell dissociation solution. The dissociation solution 
was aspirated off and the cells were loosened from the flask by spank- 
ing. These were resuspended in 10 ml of PBS and centrifuged at 
400 xg for 5 min. The resulting pellet was suspended in varying 
amounts of PBS to achieve the desired cell concentration. Cell concen- 
trations were determined by nuclei counting using a Coulter Counter. 
To measure uptake, a solution of 50pM PZ or phenothiazine in PBS 
was mixed with the cell suspension in a hand-initiated stopped-flow 
apparatus (Hi-Tech Scientific) mounted in the cuvette holder of a 
Perkin-Elmer LS-5 Fluorescence Spectrometer. Fluorescence intensity 
was recorded with respect o time using an Apple IIGS microcomputer 
equipped with a data acquisition card connected to the chart recorder 
output of the fluorimeter. The excitation wavelength for both PZ and 
phenothiazine was 330 nm while the emission wavelengths were 397 
nm and 445 nm for PZ and phenothiazine, respectively. Data were 
collected in 0.5 s intervals for 2 min. To correct for the contribution 
of cell settling to the fluorescence signal, the scattering peak occurring 
at 660 nm was monitored under identical conditions. This baseline was 
subtracted from the signal arising at the emission maximum of the 
drug. 
For efllux studies, an aliquot from a concentrated solution of PZ 
or phenothiazine in dimethyl sulfoxide was added to the growth media 
in a 175 cm2 T-flak to a final concentration of 64 ,uM. The cells were 
allowed to incubate at room temperature and atmosphere for 20 min, 
and were subsequently washed with PBS and then with dissociation 
solution, both of which contained 64 ,uM drug. The cells were sus- 
pended in PBS containing 64pM PZ, centrifuged at 400 x g for 5 min. 
and then resuspended in PBS without PZ. The suspension was mixed 
with PBS using the stopped-flow apparatus and efflux was measured 
as the decrease in fluorescence with time using the same instrumenta- 
tion as for the uptake studies. 
For pseudo-first order kinetics, the relationship between fluores- 
cence signal and integrated rate equation is: 
F = C,[l - exp(-r,t)] + C,[l - exp(-rzt)] + C, 
for uptake of PZ, and 
(Eq. 1) 
F = C,exp(-r_,t) + Cz (Eq. 2) 
for efflux, C, are constants, r, are effective rate constants, and t is 
time. These equations describe a model for accumulation in which 
external drug is accumulated into cells by two routes: 
A:BandAqB 
or effluxed as: 
B;A 
The data wer fit to equations 1 and 2 using the non-linear least- 
squares curve-fitting routines of the commercial data analysis oftware 
Kaleidagraph (Synergy Software, Reading, PA). 
2.4. Fluorscence microscopy 
Plastic chamber well slides (Nunc, Inc., Naperville, IL) were plated 
with aliquots of the three KB cell lines, which were allowed to attach 
overnight in growth media. The cells were then incubated for 20 min 
with 64 PM PZ or phenothiazine, washed once with PBS (30 s), and 
fitted with a cover slip. The slides were examined using a Zeiss micro- 
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Fig. 1. (A) KB31 cells following incubation for 20 min with 64 ,uM 
phenoxazine. PZ is rapidly accumulated into lipid droplets distributed 
throughout the cytoplasm of the KB cell line. Similar results were 
observed with both the KB85 and KBVl cell lines. These droplets also 
accumulate a wide variety of cytostatic agents such as doxorubicin 
(not shown), and may act to reduce the total intracellular drug concen- 
trations available for biological activity. (B) Enhancement of phe- 
noxazine fluorescence by organic solvents. The fluorescence of 60,~M 
PZ in PBX (broken line) and in I-butanol (solid line). Phenothiazine 
showed a similar, but less pronounced, enhancement. 
scope with an epi-fluorescence condenser and 63 x oil immersion ob- 
jectives. Excitation was performed with a broadband 450 nm filter, 
and emission was that > 520 nm. This produced faint but detectible 
fluorescence (Fig. 2). The images were photographed with a 35 mm 
camera mounted on the microscope. 
3. RESULTS 
3.1. Cellular uptake of phenoxazine and phenothiazine 
The three KB cell lines contains a heavy concentra- 
tion of hydrophobic spheroids distributed throughout 
the cytoplasm. Upon entry into the cells, PZ is rapidly 
accumulated in these regions (Fig. 1A). The environ- 
mental change results in a pronounced enhancement in 
the fluorescence quantum yield for both PZ and phe- 
nothiazine similar to that which occurs when the drugs 
are dissolved in organic solvents (Fig. 1B). This en- 
hancement provides an excellent marker for entry of the 
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Fig. 2. Uptake of phenoxazine into KBVl cells as monitored by 
fluorscence change at 397 nm (excitation at 330 nm). (A) A typical 
data set is shown (open circles) for the mixing of 50 PM PZ with 
1 x IO6 cells/ml in a stopped-flow apparatus. Similar data were ob- 
tained with KB31 and KB85 cell lines. The solid line represents the 
curve fit to a double exponential process as described by Equation 1 
(see section 2). (B,C) The resulting rate constants r, (fast) and rz (slow) 
were linearly dependent on the total cell concentration for the three 
KB cell lines. 
drugs into cells, and allows the use of fluorescence to 
monitor drug uptake. 
Fig. 2A reproduces a typical data set for uptake of PZ 
into KBVl cells. Similar data sets were also obtained for 
the KB31 and KB85 lines. The data could not be accu- 
rately fit to a single exponential process, and were there- 
fore fit to the double exponential process described by 
Equation 1. The amplitude of the slower component 
was typically 3040% of that of the faster. The resulting 
pseudo-first order rate constants were linearly depend- 
ent on the concentration of cells (Fig. 2B,C), as were the 
amplitudes of the signal. Data were collected for each 
cell line at a variety of cell concentrations, and the val- 
ues of the rate constant at 1 x lo6 cells/ml are reported 
in Table I. As can be seen, within experimental error, 
the rates of entry into the cells is independent of the 
drug sensitive or residant nature of the line. 
The uptake of phenothiazine is very similar to that for 
PZ, and could generally be fit to a single exponential 
process. However, phenothiazine is much less environ- 
mentally sensitive and does not produce the fluores- 
cence enhancement to the extent of that observed with 
PZ. Although no second component could be detected 
in the uptake, the decreased signal to noise obtained 
with phenothiazine makes resolution of a slower com- 
ponent difficult, and one may exist albeit with a magni- 
tude much less than that for the fast component re- 
corded in Table I. Interestingly, with all three cell lines 
the uptake of phenothiazine was significantly slower 
(ca. one half) than for PZ, suggesting different transport 
barriers for the two compounds. 
3.2. Cellular e&%x of phenoxazine 
Cells loaded with PZ exhibited efflux that could be 
described by a single exponential process (Fig. 3A), and 
the rate constants were nearly independent upon cell 
count (Fig. 3B). Efflux of phenothiazine from the cells 
could not be detected, presumably due to the low signal 
to noise associated with this drug. 
The determination of both uptake and efllux rates 
allows an estimate of the equilibrium partition coeffi- 
cient of PZ with cells (at lo6 cells/ml). This partition 
coefficient (P = [in]/[out]) has a value of 1.5 to 2.0 
(Table I), calculated from the relationship: 
P = (z, + zJ/z_,. Therefore, the internal and external 
Table I 
Rate constants for MDR modulator-cell interactions* 
Modula- Cell line 7, (fast) r, (slow) r-1 p’ ** 
tor 
(s-l) (s-l) (s-l) 
Fhenox- KB31 0.38 f 0.02 0.09f 0.01 0.29kO.06 1.6 
azine 
KB85 0.31 f0.03 0.02f0.01 0.22a0.02 1.5 
KBVl 0.34f 0.04 0.07f 0.02 0.21 ? 0.05 2.0 
Pheno- KB31 0.16 f 0.05 
thiazine 
KB85 0.14 f 0.02 
KBVl 0.16 f 0.01 
*At 25°C using a cell concentration of 1 x lo6 cells/ml. 
**Defined as [phenoxazine concentration inside celll/[phenoxazine 
concentration outside cell]. 
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Fig. 3. Efflux of phenoxazine from KBVl cells as monitored by fluo- 
rescence at 397 nm (330 mn excitation). (A) Data shown (open circles) 
is for the mixing of 1 x lo6 cells/ml, which had been previously incu- 
bated with 64pM PZ, with PBS in a stopped-flow apparatus. The data 
could be fit to a single exponential decay (solid line) according to 
Eqation 2 (see section 2). (B) The resulting rate constant r was slightly 
dependent on cell concentration for the three KB cell lines. 
concentrations of PZ are almost equal at physiological 
concentrations and temperatures. 
4. DISCUSSION 
As shown in Table I, both uptake and efflux of PZ 
is rapid, reaching steady-state l vels within one minute. 
This is in sharp contrast to the rates of influx of the 
cytostatic drug doxorubicin, which is accumulated into 
cells with rate constants on the order of 1O-5 to low4 s-l 
for a lo6 cells/ml suspension [6,7]. Likewise, this also 
differs from the uptake of verapamil, another MDR 
modulator, which is shown to accumulate within both 
sensitive and resistant cells over a period of two hours 
before reaching steady-state l vels [8]. These results are 
in agreement with the previous study [5] in which signifi- 
cant levels of modulation of vinblastine accumulation 
were observed within the first 5 min of incubation. The 
consequence of this rapid entry is that PZ is able to 
reach its target (as yet unidentified) before significant 
levels of cytostatic drugs have entered the cell, and 
therefore sensitization, is on this time scale, virtually 
instantaneous. Interestingly, the uptake of phenothiaz- 
ine is much slower than that for PZ: about one half as 
rapid under similar conditions. 
Due to the low value of the partition coefficient, the 
intracellular concentration of PZ will be only slightly 
higher than that found extracellularly, and this steady- 
state concentration will be rapidly approached. This is 
in direct contrast to verapamil, in which only a small 
percentage of the modulator in the external incubation 
media is accumulated very slowly into cells [8]. Thus, 
modulation by PZ can be rapidly induced or decreased 
solely through changes in the extracellular concentra- 
tion of modulator. Ramu et al. [7] have suggested that 
for effective modulation of MDR at the clinical level a 
period of pre-treatment with a modulator such as vera- 
pamil should accompany treatment with doxorubicin. 
This would not seem to be necessary with PZ. due to its 
rapid cellular equilibration. 
The lack of correlation of cellular transport of PZ to 
p-glycoprotein content (Table I) suggests that direct in- 
teraction of drug with the protein (i.e. active PZ efflux 
by pgpl70) is unlikely, or at least incidental. Similar 
conclusions have been reached in the method of vera- 
pamil and azidopine modulation [8]. 
An interesting result of these studies is the intracellu- 
lar localization of PZ, as determined by fluorescence 
microscopy (Fig. 1A). The three KB cell lines contains 
a large concentration of lipid droplets within the cyto- 
plasm. These droplets act as hydrophobic sponges for 
any number of lipophilic drugs, including PZ and phe- 
nothiazine, as well as other pgpl70 substrates uch as 
doxorubicin and rhodamine derivatives (data not 
shown). The droplets are absent from other cell lines 
such as GC3. The presence of these droplets in one cell 
line versus another can partially explain the cell line 
dependence of modulation by PZ previously reported 
[5], as well as the varying levels of PZ toxicity observed. 
Under identical extracellular concentrations, intracellu- 
lar concentrations free to develop biological activity will 
be substantially lower in the KB lines than in others 
(approximately j-fold less, based on PZ IC,,, values in 
KB85 and GC3 lines [5]). Extrapolating this to general 
pharmacology suggests that it may, in fact, be possible 
to develop modulating agents that are cell line depend- 
ent in their function. 
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